UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title

A Phase III, Multicenter, Double-Blind, Randomized, Placebo- Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-0431A (A Fixed-Dose Combination Tablet of Sitagliptin and Metformin) in Pediatric Patients with Type 2 Diabetes Mellitus


If your child has type 2 diabetes and diet, exercise, or medication aren’t helping enough, you may want to know about the Pediatric Type 2 Diabetes Studies.  

We’re evaluating an investigational drug to see if it may help control blood sugar levels in children, ages 10 to 17. Study-related care and medications may be provided at no cost. Participation may involve some risks and benefits that a study doctor can explain.

To see if your child may be eligible, call 1-866-309-0837

Start Date
October 15, 2013
End Date
October 15, 2015
Gender Preference
Age Group
10 - 17 years
Principal Investigator
Eva Tsalikian, MD
Contact Info
Sarah Salamati 1-866-309-0837 sarah-salamati@uiowa.edu
diabetes ; Sitagliptin ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.